These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8738770)

  • 1. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity.
    Lee TC; Charles BG; Steer PA; Flenady VJ
    Ther Drug Monit; 1996 Jun; 18(3):288-93. PubMed ID: 8738770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of caffeine in preterm infants: Could saliva be an alternative to serum?
    Chaabane A; Chioukh FZ; Chadli Z; Ben Fredj N; Ben Ameur K; Ben Hmida H; Boughattas NA; Monastiri K; Aouam K
    Therapie; 2017 Dec; 72(6):685-689. PubMed ID: 28964570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 7. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum caffeine concentrations in preterm neonates.
    Leon AE; Michienzi K; Ma CX; Hutchison AA
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic aspects of caffeine in premature infants.
    De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine versus theophylline for apnea in preterm infants.
    Steer PA; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (2):CD000273. PubMed ID: 10796190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.
    de Wildt SN; Kerkvliet KT; Wezenberg MG; Ottink S; Hop WC; Vulto AG; van Den Anker JN
    Ther Drug Monit; 2001 Jun; 23(3):250-4. PubMed ID: 11360033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.